Find Tocainide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 71395-14-7, Tocainide hcl, 35891-93-1, Tonocard, Tocainide monohydrochloride, 2-amino-n-(2,6-dimethylphenyl)propanamide;hydrochloride
Molecular Formula
C11H17ClN2O
Molecular Weight
228.72  g/mol
InChI Key
AMZACPWEJDQXGW-UHFFFAOYSA-N
FDA UNII
2K7I38CKN5

Tocainide
An antiarrhythmic agent which exerts a potential- and frequency-dependent block of SODIUM CHANNELS.
1 2D Structure

Tocainide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-amino-N-(2,6-dimethylphenyl)propanamide;hydrochloride
2.1.2 InChI
InChI=1S/C11H16N2O.ClH/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12;/h4-6,9H,12H2,1-3H3,(H,13,14);1H
2.1.3 InChI Key
AMZACPWEJDQXGW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=CC=C1)C)NC(=O)C(C)N.Cl
2.2 Other Identifiers
2.2.1 UNII
2K7I38CKN5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hydrochloride, Tocainide

2. Tocainide

3. Tocainide Monohdyrochloride, (r)-isomer

4. Tocainide Monohydrobromide, (r)-isomer

5. Tocainide Monohydrochloride

6. Tocainide Monohydrochloride, (+-)-isomer

7. Tocainide Monohydrochloride, (s)-isomer

8. Tocainide, (+-)-isomer

9. Tocainide, (r)-isomer

10. Tocainide, (s)-isomer

11. Tonocard

12. W 36095

13. W-36095

14. W36095

15. Xylotocan

2.3.2 Depositor-Supplied Synonyms

1. 71395-14-7

2. Tocainide Hcl

3. 35891-93-1

4. Tonocard

5. Tocainide Monohydrochloride

6. 2-amino-n-(2,6-dimethylphenyl)propanamide;hydrochloride

7. 2-amino-n-(2,6-dimethylphenyl)propanamide Hydrochloride

8. Tocainide Hydrochloride [usp]

9. 2k7i38ckn5

10. Tocainide (hydrochloride)

11. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride

12. Dsstox_cid_25540

13. Dsstox_rid_80942

14. Dsstox_gsid_45540

15. Tocainide Hydrochloride (usp)

16. Taquidil

17. Xylotocan

18. Cas-35891-93-1

19. Tocainide-hydrochloride

20. Unii-2k7i38ckn5

21. Tonocard (tn)

22. Einecs 275-361-2

23. 2-amino-n-(2,6-dimethylphenyl)propanamide Monohydrochloride

24. Ncgc00017005-01

25. 2-amino-2',6'-propionoxylidide Hydrochloride

26. Schembl122779

27. Tocainide Hydrochloride- Bio-x

28. Chembl1200773

29. Dtxsid5045540

30. Hy-b1798a

31. Hms1571m15

32. Tocainide (+-)-form Hydrochloride

33. Tox21_110732

34. Tox21_500344

35. Tox21_110732_1

36. Ccg-213604

37. Lp00344

38. Tocainide Hydrochloride [mart.]

39. Tocainide Hydrochloride [vandf]

40. Tocainide Hydrochloride [who-dd]

41. Ncgc00162129-06

42. Ncgc00261029-01

43. Bt164480

44. Tocainide (+/-)-form Hydrochloride

45. Cs-0013838

46. Tocainide Hydrochloride [orange Book]

47. Tocainide Hydrochloride [usp Impurity]

48. D02088

49. 6-bromo-4-quinazolinecarboxylic Acidammonium Salt

50. Tocainide Hydrochloride, >=98% (hplc), Solid

51. Sr-01000763682

52. Tocainide (+/-)-form Hydrochloride [mi]

53. Sr-01000763682-3

54. Q27254865

55. (1)-2-amino-n-(2,6-dimethylphenyl)propionamide Hydrochloride

56. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride, (+-)-

57. Tocainide Hydrochloride, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 228.72 g/mol
Molecular Formula C11H17ClN2O
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass228.1029409 g/mol
Monoisotopic Mass228.1029409 g/mol
Topological Polar Surface Area55.1 Ų
Heavy Atom Count15
Formal Charge0
Complexity196
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Voltage-Gated Sodium Channel Blockers

A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty